Metsera (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- November 13, 2024
- Vertical
- Biotech
- Funding URL
- View Funding Page
- Funding Amount:
- $215,000,000
Company Info
- Traction
- Metsera has raised over $500 million in total funding, with promising Phase 1 results for its lead product and ongoing clinical trials.
- Organizations Involved
- Amneal Pharmaceuticals
- Company Description
- Metsera is a biotech startup focused on developing innovative treatments for obesity, including a long-acting GLP-1 injection and other obesity therapies. The company aims to improve existing obesity treatments and explore combination therapies for enhanced patient outcomes.
- Market
- Obesity treatment
- Coinvestors
- Wellington Management, Venrock Healthcare Capital Partners, Fidelity Management & Research, Janus Henderson Investors, T. Rowe Price